收藏切换
Development and application of a core data set for bioequivalence trials based on CDISC standards
收藏切换
PDF
Si-qi WANG1, Zhao-he LI2, Min-guang ZHANG2, Na XIE1, Ya-he ZHU1, Ying WU1, Heng-hui LIU2
Chinese Journal of Clinical Pharmacology | 2026, 42(2) : 291 - 296
Less
收藏切换
Chinese Journal of Clinical Pharmacology | 2026, 42(2): 291-296
Regulatory Science Column
Development and application of a core data set for bioequivalence trials based on CDISC standards
Full
Si-qi WANG1, Zhao-he LI2, Min-guang ZHANG2, Na XIE1, Ya-he ZHU1, Ying WU1, Heng-hui LIU2
Affiliations
  • 1.School of Public Health, North China University of Science and Technology, Tangshan 063210, Hebei Province, China
  • 2.Beijing Yurong Medical Data Technology Co., Ltd., Beijing 100176, China
Published: 2026-01-28 doi: 10.13699/j.cnki.1001-6821.2026.02.023
Outline
收藏切换
Objective

To address issues such as low efficiency and poor consistency in the submission of bioequivalence trial data under the Clinical Data Interchange Standards Consortium standards, this study aimed to develop a set of reusable standardized core data sets to improve data preparation efficiency and regulatory submission quality.

Methods

A systematic review of multiple approved BE trial projects was conducted, covering different trial designs, dosage forms, and study types. Common data structures and mapping rules were extracted through business analysis, and standardized data set templates covering both SDTM and ADaM layers were developed in strict accordance with CDISC standards.

Results

This study summarized 274 SDTM and 338 ADaM data element-specific attributes applicable to bioequivalence trials. A set of standardized core data sets suitable for most BE trial scenarios was established and successfully applied in a two-formulation, two-period, two-sequence crossover BE study evaluating a gel patch.

Conclusion

The standardized dataset constructed in this study provides a preliminary framework for the standardization of BE trial data, which requires further validation through large-scale applications to clarify its applicability and robustness in enhancing the standardization level and work efficiency of BE trial data processing. It holds significant practical value for ensuring data quality and improving the success rate of submissions, while also serving as a referenceable example for the development of foundational datasets within the industry.

CDISC  /  bioequivalence trial  /  core data set  /  SDTM  /  ADaM  /  data harmonization
Si-qi WANG, Zhao-he LI, Min-guang ZHANG, Na XIE, Ya-he ZHU, Ying WU, Heng-hui LIU. Development and application of a core data set for bioequivalence trials based on CDISC standards[J]. Chinese Journal of Clinical Pharmacology, 2026 , 42 (2) : 291 -296 . DOI: 10.13699/j.cnki.1001-6821.2026.02.023
Year 2026 volume 42 Issue 2
PDF
138
33
Cite this Article
BibTeX
Article Info
doi: 10.13699/j.cnki.1001-6821.2026.02.023
  • Receive Date:2025-12-27
  • Online Date:2026-08-06
  • Published:2026-01-28
Article Data
Affiliations
History
  • Received:2025-12-27
Affiliations
    1.School of Public Health, North China University of Science and Technology, Tangshan 063210, Hebei Province, China
    2.Beijing Yurong Medical Data Technology Co., Ltd., Beijing 100176, China
References
Share
https://castjournals.cast.org.cn/joweb/zglcylxzz/EN/10.13699/j.cnki.1001-6821.2026.02.023
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT